FGF23 and hyperphosphatemia: In T2DM patients with chronic renal insufficiency and renal bone disease, hyperphosphatemia causes dysfunction of the FGF23–1,25-(OH)2-vitamin D–PTH axis and exacerbates the risk of fracture (49) (Figure 2).